FDA Inspection
BEO Pharma IncBEO Pharma Inc – FDA Inspection, Sep 18, 2026
Record Details
This FDA Inspection record concerns BEO Pharma Inc, with an inspection on September 18, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 19e1311a-bde9-484c-9ebd-ff49e147a1b0
Inspection Facts
- Inspection number
- 1337028
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.84(b)Representative Samples
- 21 CFR 211.89Quarantine of Rejected Components et. al.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BEO Pharma Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2024 | OAI | Florida District Office | Drug Quality Assurance |
Other documents for BEO Pharma Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.